Pictet Asset Management
CRVS icon

Pictet Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Pictet Asset Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+15,629
New +$217K ﹤0.01% 1904

Other funds holding CRVS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Pictet Asset Management's CRVS Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Corvus Pharmaceuticals (CRVS) in Q2 2026: 15,629 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1904 among its holdings.

24 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Pictet Asset Management held 15,629 shares of Corvus Pharmaceuticals worth $233K as of Q2 2026.
  • Corvus Pharmaceuticals was a new Pictet Asset Management position in Q2 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1904 holding.
  • 24 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.